At ACC 2010, Philips Healthcare will focus on the full spectrum of cardiology care – from diagnosis and treatment to disease management and home monitoring to enhance patient care.

Philips Healthcare's CT systems use the iDose application that enables clinicians to reduce X-ray radiation dose by up to 80 percent.

February 8, 2010 – Partnering with leading implantable cardioverter defibrillators (ICD) and pacemaker manufacturers, ScottCare Corp. has consolidated device information into one common platform with enhanced reporting and analysis capabilities. The newst addition to the CardioView Dx suite of diagnostic solutions is OneView, designed to manage all pacer and ICD patients and information.

McKesson’s Practice Partner is an award-winning electronic health record (EHR) and medical billing software solution for physician practices which improves efficiency, quality of care, and communication while reducing time spent on administrative tasks.

February 8, 2010 – The FDA cleared the Sorin Paradym CRT Model 8750, a cardiac resynchronization therapy defibrillator (CRT-D), which features a new battery technology that delivers 37 joules, one of the highest energy levels of any implantable cardiac defibrillator (ICD).

February 5, 2010 – European CE mark approval was granted and first implants reported for the Fortify and Fortify ST implantable cardioverter defibrillators (ICD) and Unify cardiac resynchronization therapy defibrillator (CRT-D). The reduced size of these new devices compared to those of previous generations creates one of the smallest available device footprints in the industry.

February 5, 2010 – A new, large-scale pivotal phase III trial has been initiated for edoxaban to evaluate its safety and efficacy in reducing recurrent venous thromboembolic (VTE) complications in patients with deep-vein thrombosis (DVT) and/or pulmonary embolism (PE).

February 5, 2010 – Enrollment is complete for the trial of a polymer-based gel that rapidly transitions to a solid at body temperature, forming a plug that can temporarily occlude blood vessels for heart surgery.

“Information is the lifeblood of modern medicine. Health information technology is destined to be its circulatory system.”(1) When Dr. David Blumenthal’s words appeared in the New England Journal of Medicine(2) last month, he was referring to the IT infrastructure the Department of Health and Human Services is building across the United States.

February 5, 2010 – Cardiac surgical ablation system maker AtriCure agreed to pay $3.8 million plus interest for allegedly using illegal kickbacks and an off-label marketing campaign to induce physicians and hospitals to perform its costly inpatient cardiac surgical ablation procedures over less expensive outpatient catheter ablation procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now